Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
US |
|
Haulotte Group SA
PAR:PIG
|
FR |
Wall Street
Price Targets
CBIO Price Targets Summary
Crescent Biopharma Inc (Pre-Reincorporation)
According to Wall Street analysts, the average 1-year price target for
CBIO
is 28.9 USD
with a low forecast of 22.22 USD and a high forecast of 36.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CBIO's stock price target?
Price Target
28.9
USD
According to Wall Street analysts, the average 1-year price target for
CBIO
is 28.9 USD
with a low forecast of 22.22 USD and a high forecast of 36.75 USD.
What is Crescent Biopharma Inc (Pre-Reincorporation)'s Revenue forecast?
Projected CAGR
-14%
For the last 13 years the
compound annual growth rate for
Crescent Biopharma Inc (Pre-Reincorporation)'s revenue is
-3%.
The projected
CAGR
for the next 3 years is
-14%.
